A strain of mice genetically deficient in blood catalase should be of considerable value in studying the possible role of hydrogen peroxide in carcinogenesis and cancerolysis, as suggested by WARBURG, GAWEHN, and GEISSLER (1957) and by HOLMAN (1957), and in assessing the possible role of H,O, in radiation lethality. That such a strain could be viable appeared probable from the work of TAKAHARA (1952), AEBI et al. (1961 ) , and SZEINBERG et al. (1963), with humans, and RADEV (1958) with guinea pigs. Therefore a large scale search for low-catalase mutants among the progeny of irradiated mice was initiated.
tion of a mouse litter containing individuals with blood catalase levels approximately 1 % of normal. The present communication details the search for mutants and describes five mutant lines which have been obtained.
MATERIALS A N D METHODS
A. Initial source of mutants: Mice used as the initial source of possible mutants were discards from two experiments at Oak Ridge National Laboratory. In these experiments, designed to obtain radiation-induced visible mutations at specific loci (RUSSELL 1951), mice examined were offspring of irradiated fathers, who had received a total dose of 600R in fractionated exposures.
B. Analytical techniques: Blood was drawn from the orbital sinus (RILEY 1960) and laked in an appropriate volume of cold water. I n the initial screening, a recently published (FEINSTEIN et al. 1964 .a) rapid, semi-quantitative blood catalase assay was used. After this stage, the quantitative perborate assay (FEINSTEIN 1949) was employed. Mice were weaned and sexed at four weeks of age. and blood catalase was assayed at six weeks.
RESULTS
One hundred and ten mice, comparable to the mice to be screened except that there had been no parental irradiation, were quantitatively assayed for blood catalase to determine the normal distribution. The results are shown in Figure 1 . Mean and standard deviation of the blood catalase activity was 149 f 14 perborate units (PU) per ml of whole blood. Thus it can be estimated that approximately 1 % of normal animals might have blood catalase lying outside the range of 113-185 PU/ml (mean 2 2.576~). There is a small but real sex difference (male mean and standard deviation 1432 15 PU/ml; female, 153* 12 PU/ml; df=108; tz3.88; P<O.OOl), but in the interests of speed and simplicity the sex difference R. N. FEINSTEIN et al. was ignored during the screening. Since, as noted below, a "subnormal" catalase activity was defined as one differing from normal by almost 40 perborate units, it seemed to us that no real advantage could accrue by special consideration of the 1 I-unit sex difference. On the basis of the human experience, it was assumed that any heterozygotes would have catalase activity approximately 50% of normal, presumably with a distribution curve comparable to that for normal antmals. Based on these assumptions, the screening test was adjusted to note as subnormal any blood catalase value equal to or lower than the average of the normal and that presumed for the heterozygote, or 112 PU/ml. This figure is in a sense arbitrary, but it is based on the consideration that the cost of missing a h:gh-catalase mutant heterozygote is directly proportional to the value of the mutant, which in turn is inversely proportional to its frequency in the population examined. Similarly, the cost of testing an animal that will actually prove to be wild-type, but on the low side of the distribution curve, may be considered to be directly proportional to the frequency, i.e., the more common the occurrence of a mutation, the less point is there in spending effort on dubious possibilities. The mathematical statement of these opposing considerations then simplifies, if one assumes equal proportionality constants, to the concept that the ideal cut-off point is the average of the normal mean and the expected heterozygote mean.
A total of 12,,306 mice were then screened semiquantitatively for subnormal blood catalase activity, and 56 prospective heterozygotes were found. These 56 mice were then assayed quantitatively, and the number was reduced to 42. These remaining 42 mice (39 males, three females) 'were then mated with normal animals, and low catalase progeny were backcrossed to the suspect parent. In 35 of the mice, this test revealed no clear genetic abnormality; although the backcross generation frequently tended toward lower catalase activity, presumably because of the deliberate selection of low catalase progeny, catalase values remained within normal limits. An example is shown in Figure 2 .
The remaining seven animals, individually described below, consist of five FIGURE 3.-Effect of backcrossing in mice of low, genetically abnormal, blood catalase. "Original animal" of this figure is progenitor of the M2 mutant line described in text. The blood catalase level of 92 PU/ml of both this animal and that described in Figure 2 is purely coincidental; these are separate, unrelated individuals.
progeny, of the following blood catalase levels (PU/ml) : 0.5, 0.6, 1.5; 64, 68, 69; 112, 121, 135, 144. There are thus clearly represented in this one litter examples of homozygote, heterozygote, and normal. From these basic animals a thriving colony of truebreeding acatalasemic mice was established. Although these mice seem always to have a slight residue of blood catalase and so are more properly called hypocatalasemic, it is preferred to use the term "acatalasemic", first because it is consonant with the usage of TAKAHARA (1952) and AEBI et al. (1961) with human acatalasemics, and second because the other four mutants, showing a level of blood catalase which is much higher than this, yet still subnormal, are more appropriately termed "hypocatalasemic".
The phenotypic expression of the MI mutation shows distinct discontinuities between normal, heterozygote, and homozygote, and it is possible to equate the normal animal with blood catalase levels above 11 0 PU/ml; the heterozygote, with 40 to 100 PU/ml; and the homozygote, below 10 PU/ml. On the basis of these groupings and the known genetic history, it is possible to describe the results of various types of matings. This is illustrated by Figure 4 , presenting the results of 14 heterozygote-heterozygote matings (70 progeny).
Mutants 2, 3,4, and 6 (M2, M3, M4, and M6) : These four may be described together, for convenience. The original animals were all males, exhibiting blood catalase of 92, 86, 83, and 110 PU/ml, respectively. Using M 2 as a typical example, the original male, mated to a normal female, produced among other progeny a daughter of 109 PU/ml. Backcrossing this daughter to the sire produced a litter of four mice: 29, 111, 118, and 155 PU/ml. Again three classes of progeny are evident, but the apparent heterozygote here is higher than M1 (it ultimately proved to range from about 80 to 120 PU/ml, as indicated in Table 1) , and the homozygote is also appreciably higher than the M1 homozygote. noted that although the homozygote usually is readily distinguishable from the heterozygote, the heterozygote distribution overlaps appreciably with the normals. Because of the considerable overlap in some mutants between heterozygote and normal values, special measures had to be taken to determine the percentage of each. This was desirable in order to determine the nearness of fit to the expected Mendelian ratios in the progeny of heterozygote-heterozygote matings. To accomplish this, a number of definite heterozygotes of each mutant were produced by crossing the readily identifiable homozygote with known normal mice. The individual blood catalase activity of the progeny (approximately 100 for each mutant) were then used for the preparation of distribution curves, and the mean and standard deviations were obtained. The same was done for all known homozygotes of each mutant. Finally, a computer program was established, in which, in the case of each mutant, the mean and standard deviation for normal, heterozygote, and homozygote populations were presented, as well as the individual catalase activities of progeny of heterozygote-heterozygote matings. The program was designed to sort these individuals, on a statistical basis, into percentages of homozygote, heterozygote, and normal. The results are presented in Table 1 . It will be noted that in all mutant lines except MI, the estimated percent of heterozygotes is higher than the expected 50%; the estimated percent of homozygotes is low; and, surprisingly, the percent of normal progeny is also low. It was possible partially to verify the validity of the computer program by using the data from M1, where homozygote, heterozygote, and normal are readily distinguishable.
The results provide support for the validity of the program:
Homozygote Heterozygote Norma2
By actual count (Figure 4 In early work 'with M3 and M4 mice, a transient anemia was common. In later generations of these same lines, no anemia is observed.
Mutants 5 and 7 (M5 and M7): These two lines are also conveniently considered together. Original animals were both males, of blood catalase activity 93 and 110 PU/ml, respectively. Repeated backcrossing and inbreeding within these strains has produced two lines which regularly produce mice with blood catalase activities approximately 90 to 1 10 PU/ml, but never significantly lower. These lines, as indicated earlier, are still under genetic analysis.
Determination of possible d e l i s m between mutant lines:
It is of both theoretical and practical interest to determine whether the various mutations described have all occurred at one locus, or whether more than one locus is represented. The theoretical interest stems from the question of whether more than one gene may participate in the biosynthesis of catalase. The practical importance depends on the fact that if all the mutations are allelic, it will not be possible from these lines to obtain an animal of lower catalase activity than M1; if more than one gene locus were involved, it may be possible.
The test for allelism or nonallelism was made by mating all possible combinations of homozygotes (Ml x M2, M1 x M3, etc.), then mating each set of progeny among themselves. Two possibilities are considered: (a) If the two mutations are allelic, a and a', using the letter a for illustrative purposes only, the F, The results of these tests are given in Table 2 , which strongly suggests that only one gene locus is represented. In fact, the data do not exclude the possibility that some of these mutations may actually be identical mutations. This question, and table, are discussed further below.
Corresponding experiments between M5 and M7, and the other five mutants, show a less clear-cut picture. Some normal animals do appear in F,, but this cannot be considered proof that M5 and M7 are mutations of other loci, since we are not yet able to guarantee the homozygosity of our M5 and M7 mice.
DISCUSSION
Beyond the questions posed by mutants M5 and M7, genetic analysis of which is continuing, the most interesting considerations would seem to revolve about the matter of whether the five established mutations are nonallelic, allelic, or even in some cases identical.
It is perhaps beyond the capabilities of genetic techniques to determine whether or not any of the mutants M2, M3, M4, and M6 are identical. Physicochemical and immunochemical characterization of the catalase produced would seem to offer most hope for information in this direction, for if the catalase molecules were to prove to be qualitatively identical, then presumably the mutations are identical, since no quantitative differences are to be seen between the parental generations and the F, and F, generations derived from homozygote-homozygote crosses of M2, M3, M4, and M6 (see Table 2 ). The data presented do, however, suggest that the five mutations described are probably allelic. This conclusion is based on two chief considerations: (a) As described earlier, one would expect that the F, generation of intermutant crosses would include some animals with catalase levels higher o r lower than the parental generation. No such animals were produced. Because of the relatively small number of animals involved, however (a total of 323 F,), this cannot be considered completely conclusive.
(b) It is possible to calculate "expected" blood catalase levels of inter-mutant F, mice, and heterozygotes of each mutant, based on either the assumption of allelism, or of nonallelism. As will be seen, only the assumption of allelism fits at all well:
(1) Mutants are allelic: If it is assumed that all five mutants are alleles, and that each genome independently is responsible for half the catalase activity of the homozygote (the assumption of simple genetic additivity), results of Table 3 are obtained. Thus the assumption of allelism with additivity provides a quite good No readily apparent scheme of simple additive effects of nonallelic mutations has been devised which can account for the values observed in the F, generation.
Thus the quantitative differences in catalase levels observed in the inter-mutant F, animals is by far the most readily explained on the basis of allelic mutations with essentially additive effects. R. N. FEINSTEIN et al. One last alternative must be considered, namely that the various mutations are not actually alleles, but closely linked nonalleles. It is difficult to decide this conclusively in such populations as used here. Necessary limitations on the sample sizes that can be handled will not permit the detection of crossover types when crossing over is quite infrequent.
In brief, the surprisingly good fit on the basis of simple additivity of allelic mutations in accounting for the heterozygote values of each of the mutants and especially for the F, generation between the five mutants, coupled with the difficulty of devising a scheme to explain the observations on the assumption of various kinds of interactions between nonallelic genes, plus the failure to observe any individuals in any of the F, generation remotely approaching normality or falling below the level of the lower parental strain, all lend supporting evidence for the existence of allelic mutations, which is certainly the most economical hypothesis on the basis of available evidence.
No explanation is offered for the occasional appearance in Table 2 of an F, animal somewhat higher in blood catalase than the parental range, other than chance variation. In each of these instances it will be observed that the value is very considerably closer to the mutant than to the normal range (Table 1 ) .
The earlier noted sex difference in normal mice is not considered to becloud the issue in the genetic analysis. Not only is it a relatively small (though significant) difference in normal mice; it actually cannot be observed in any of the mutants, or in the F, of inter-mutant crosses.
The data offer sufficient evidence of the existence of a mouse gene that has not been previously identified. It behaves as a partial recessive ( f -I-> f M > M M ) , and there is probably a multiple allelic series. We suggest at this time that the gene be designated "Cs". On the assumption of allelism for mutants herein designated as MI, M2, M3, M4, and M6, the appropriate genetic nomenclature should now be Csb, Csc, Csd, Cse, and Csf. The wild-type, or LLnormal" gene is properly designated CP. These designations are in accord with the latest (1965) proposed revision of the Genetic Nomenclature Rules for Mice (M. C. GREEN, personal communication to D. GRAHN, Argonne National Laboratory. ) It is extremely unlikely that the allelic gene series discussed herein is related to the mouse Ce gene recently described by HESTON, HOFFMAN, and RECHCIGL (1965) . The Ce gene effects the catalase of liver, but neither that of kidney nor (presumably) that of blood. The Cs gene effects blood and kidney catalase even more strikingly than it does that of liver (FEINSTEIN, HOWARD, and BRAUN, to be published). Further, Ce is shown to be an instance of low level of activity dominant to high, whereas Cs is a partial recessive, with -t -I-> -t M > M M .
Studies have been initiated here to determine whether any linkage exists between Ce and Cs.
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